Transcatheter aortic valve implantation (TAVI) in patients at intermediate surgical risk

Home  /  National Uptake and Case Studies  /  Transcatheter aortic valve implantation (TAVI) in patients at intermediate surgical risk
CountryAgencyStatusLinkDetails of use
AustriaLBI-HTA2019LINKNational adaptation. Made no changes to the information. Translation of summary in German.
IrelandHIQAOngoingNational HTA including economic evaluation of TAVI in patients at low and intermediate risk underway. The evidence is being updated, and given the broader indication, additional evidence synthesis will be required.
ItalyASSR REROngoingDissemination of REA to plan regional report.
NetherlandsZIN2019National adaptation with significant changes made. The indication was broader than the one used in the EUnetHTA report and therefore the evidence was updated.
NorwayNIPHNO2019National adaptation.
RomaniaNSPHMPDB2019Dissemination - Letter to the MoH. Link on the NSPHMPDB Facebook page.
SpainSCS2019Dissemination (via Twitter)
UK (England)NICE2019The report will be included in NHS evidence as a source of information for local decision making.
UK (Scotland)SHTG2019LINKNational adaptation. Added local information.
UK (Wales)HTW2019Read the assessment for background information.
SwitzerlandFOPHRead the assessment for background information. Used the assessment to inform the evaluation or consideration of a company submission of evidence.